Placebo Procedure

PROCEDURE3 trials

Sponsors

United States Naval Medical Center, San Diego, Imperial College London, King's College London

Conditions

Coronary Artery DiseaseHeart Failure With Preserved Ejection Fraction (HFPEF)Post Traumatic Stress Disorder (PTSD)Refractory Angina

Phase 2

A Randomized, Placebo-Controlled Trial of Stellate Ganglion Block in the Treatment of Post Traumatic Stress Disorder

CompletedNCT01629537

United States Naval Medical Center, San DiegoPost Traumatic Stress Disorder (PTSD)

Start: 2011-06-30End: 2016-04-30Target: 41Updated: 2017-03-30

Coronary Artery Stents in Heart Failure With Preserved Ejection Fraction

RecruitingNCT07560436

King's College LondonHeart Failure With Preserved Ejection Fraction (HFPEF), Coronary Artery Disease

Start: 2026-03-23End: 2029-08-01Target: 350Updated: 2026-05-01

Unknown Phase

Coronary Sinus Reducer Objective Impact on Symptoms, MRI Ischaemia and Microvascular Resistance

Imperial College LondonRefractory Angina

Start: 2021-05-21End: 2024-01-31Target: 50Updated: 2023-10-30

Related Papers

Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial.

2024-04-0849 citations

A double-blind, randomised, placebo-controlled trial of the coronary sinus Reducer in refractory angina: design and rationale of the ORBITA-COSMIC trial

EuroIntervention2024-02-014 citations

A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina

New England Journal of Medicine2023-11-11174 citations